• AJMCAJMC
  • Center for Biosimilars
The Center for Biosimilars - Biosimilars, Health Economics & Insights
The Center for Biosimilars - Biosimilars, Health Economics & Insights
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
SubscribeBIOSIMILAR APPROVALS
  • About
  • Editorial
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2025 MJH Life Sciences and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Advertisement
Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Editorial
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Legal

  1. home

Infographic: Biosimilar Substitution Laws By State

March 21st 2017

By Christina Mattina

Article

Mylan's Settlement With Genentech and Roche Opens US Market for Trastuzumab Biosimilar

March 14th 2017

By Surabhi Dangi-Garimella, PhD

Article

European Industry Groups Urge Caution on Biosimilar Switching

March 10th 2017

By Jackie Syrop

Article

Siliq Approved Without a Suffix

March 7th 2017

By Jackie Syrop

Article

New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab

March 7th 2017

By Jackie Syrop

Article

New Mexico Senate Passes Bill for Biosimilar Substitution

February 28th 2017

By Surabhi Dangi-Garimella, PhD

Article

Advertisement
Advertisement